BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 15471225)

  • 21. Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients.
    Jacobson MA; Sinclair E; Bredt B; Agrillo L; Black D; Epling CL; Carvidi A; Ho T; Bains R; Adler SP
    J Clin Virol; 2006 Mar; 35(3):332-7. PubMed ID: 16387547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of T cell epitopes by the use of rapidly generated mRNA fragments.
    Britten CM; Meyer RG; Graf C; Huber C; Wölfel T
    J Immunol Methods; 2005 Apr; 299(1-2):165-75. PubMed ID: 15914199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relevance of peptide avidity to the T cell receptor for cytomegalovirus-specific ex vivo CD8 T cell cytotoxicity.
    Villacres MC; Lacey SF; Auge C; Longmate J; Leedom JM; Diamond DJ
    J Infect Dis; 2003 Sep; 188(6):908-18. PubMed ID: 12964124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
    Borghan MA; Oka S; Takiguchi M
    Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells.
    Melenhorst JJ; Solomon SR; Shenoy A; Hensel NF; McCoy JP; Keyvanfar K; Barrett AJ
    J Immunother; 2006; 29(4):436-43; discussion 365-6. PubMed ID: 16799339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfections.
    Jin X; Demoitie MA; Donahoe SM; Ogg GS; Bonhoeffer S; Kakimoto WM; Gillespie G; Moss PA; Dyer W; Kurilla MG; Riddell SR; Downie J; Sullivan JS; McMichael AJ; Workman C; Nixon DF
    J Infect Dis; 2000 Jan; 181(1):165-75. PubMed ID: 10608763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory T cells generated during cytomegalovirus in vitro stimulation of mononuclear cells from HIV-infected individuals on HAART correlate with decreased lymphocyte proliferation.
    Jesser RD; Li S; Weinberg A
    Virology; 2006 Sep; 352(2):408-17. PubMed ID: 16782163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and characterization of HIV-1-specific CD8+ T cell epitopes presented by HLA-A*2601.
    Satoh M; Takamiya Y; Oka S; Tokunaga K; Takiguchi M
    Vaccine; 2005 May; 23(29):3783-90. PubMed ID: 15893615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of EBV-specific T cells for adoptive immunotherapy: a novel protocol using formalin-fixed stimulator cells to increase biosafety.
    Hammer MH; Brestrich G; Mittenzweig A; Roemhild A; Zwinger S; Subklewe M; Beier C; Kurtz A; Babel N; Volk HD; Reinke P
    J Immunother; 2007; 30(8):817-24. PubMed ID: 18049333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recognition of CMV pp65 protein antigen by human CD4 T-cell lines induced with an immunodominant peptide pool.
    Li Pira G; Bottone L; Ivaldi F; Pelizzoli R; Bracci L; Lozzi L; Scarso L; Tripodi G; Manca F
    Hum Immunol; 2004 May; 65(5):537-43. PubMed ID: 15172454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A sealed and unbreached system for purification, stimulation, and expansion of cytomegalovirus-specific human CD4 and CD8 T lymphocytes.
    Li Pira G; Bottone L; Ivaldi F; Pelizzoli R; Risso M; Tripodi G; Manca F
    Transfusion; 2006 Dec; 46(12):2053-62. PubMed ID: 17176316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
    Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
    J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid generation of CMV pp65-specific T cells for immunotherapy.
    Bao L; Sun Q; Lucas KG
    J Immunother; 2007; 30(5):557-61. PubMed ID: 17589296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor antigen-specific T-cell expansion is greatly facilitated by in vivo priming.
    Dang Y; Knutson KL; Goodell V; dela Rosa C; Salazar LG; Higgins D; Childs J; Disis ML
    Clin Cancer Res; 2007 Mar; 13(6):1883-91. PubMed ID: 17363545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional memory CD8+ T cells can be generated in vivo without evident T help.
    Andrews MR; Peters T; Khammanivong V; Leggatt GR; Frazer IH; Fernando GJ
    Vaccine; 2004 Dec; 23(6):739-42. PubMed ID: 15542197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individuals.
    Thorn M; Tang S; Therrien D; Kløverpris H; Vinner L; Kronborg G; Gerstoft J; Corbet S; Fomsgaard A
    APMIS; 2007 Jun; 115(6):757-68. PubMed ID: 17550385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.
    Sinclair E; Tan QX; Sharp M; Girling V; Poon C; Natta MV; Jabs DA; Inokuma M; Maecker HT; Bredt B; Jacobson MA;
    J Infect Dis; 2006 Dec; 194(11):1537-46. PubMed ID: 17083038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of host immunity to cytomegalovirus pp150 (UL32).
    La Rosa C; Wang Z; Lacey SF; Markel SF; Sharma MC; Martinez J; Lalimarmo MM; Diamond DJ
    Hum Immunol; 2005 Feb; 66(2):116-26. PubMed ID: 15694996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progression to CMV end-organ disease in HIV-1-infected individuals despite abundance of highly differentiated CMV-specific CD8+ T-cells.
    Bronke C; Westerlaken GH; Miedema F; Tesselaar K; van Baarle D
    Immunol Lett; 2005 Mar; 97(2):215-24. PubMed ID: 15752561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CTL escape and increased viremia irrespective of HIV-specific CD4+ T-helper responses in two HIV-infected individuals.
    Geels MJ; Jansen CA; Baan E; De Cuyper IM; van Schijndel GJ; Schuitemaker H; Goudsmit J; Pollakis G; Miedema F; Paxton WA; van Baarle D
    Virology; 2006 Feb; 345(1):209-19. PubMed ID: 16246391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.